{"id":344177,"date":"2026-11-11T18:12:27","date_gmt":"2026-11-11T12:42:27","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/"},"modified":"2026-11-11T18:12:27","modified_gmt":"2026-11-11T12:42:27","slug":"godavari-drugs-q2-results-fy27-pat-0-96-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/","title":{"rendered":"Godavari Drugs Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 28.23 Cr, PAT Rs 0.96 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Godavari Drugs Q2 Results FY27 were declared on 11 November 2026. These quarterly results on a Standalone basis show revenue of Rs 28.23 Cr, up 5.93% from Rs 26.65 Cr a year earlier, and net profit of Rs 0.96 Cr, down 4% from Rs 1 Cr. Operating Profit stood at Rs 2.8 Cr, up 40% YoY. The YoY growth picture is detailed in the Financial Highlights table and the sections that follow.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/godavari\/godavari-drugs-ltd-share-price-today\">Godavari Drugs Ltd<\/a> (GODAVARI) Q2 Results FY27 announced on 11 November 2026, covering the company&#8217;s financial performance for the July to September quarter. The Godavari Drugs Q2 Results FY27 record revenue of Rs 28.23 Cr and net profit of Rs 0.96 Cr on a Standalone basis. The results date of 11 November 2026 marks the point from which this standalone results filing for Godavari Drugs is available to investors tracking NSE and BSE disclosures, and the sections below read the numbers in order.<\/p>\n<p>This results analysis of Godavari Drugs Q2 Results covers the financial highlights, the business drivers disclosed for the quarter, the FY27 outlook and the risks worth tracking. Revenue moved higher while net profit moved lower on a YoY basis, and the Financial Highlights comparison below sets each line against the same quarter a year earlier so the YoY movement can be read at a glance.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Godavari_Drugs_Q2_Results_FY27_Financial_Highlights\" title=\"Godavari Drugs Q2 Results FY27: Financial Highlights\">Godavari Drugs Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Key_Takeaways_from_Godavari_Drugs_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from Godavari Drugs Q2 Results: What Stands Out\">Key Takeaways from Godavari Drugs Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Godavari_Drugs_Q2_Results_FY27_Performance_Analysis\" title=\"Godavari Drugs Q2 Results FY27: Performance Analysis\">Godavari Drugs Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#FY27_Outlook_After_Godavari_Drugs_Q2_Results\" title=\"FY27 Outlook After Godavari Drugs Q2 Results\">FY27 Outlook After Godavari Drugs Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Key_Risks_to_Watch_After_Godavari_Drugs_Q2_Results_FY27\" title=\"Key Risks to Watch After Godavari Drugs Q2 Results FY27\">Key Risks to Watch After Godavari Drugs Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Net_Profit_Fell_YoY\" title=\"Net Profit Fell YoY\">Net Profit Fell YoY<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Low_Return_on_Equity\" title=\"Low Return on Equity\">Low Return on Equity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Modest_Return_on_Capital_Employed\" title=\"Modest Return on Capital Employed\">Modest Return on Capital Employed<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Frequently_Asked_Questions_on_Godavari_Drugs_Q2_Results_FY27\" title=\"Frequently Asked Questions on Godavari Drugs Q2 Results FY27\">Frequently Asked Questions on Godavari Drugs Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_are_Godavari_Drugs_Q2_Results_FY27\" title=\"What are Godavari Drugs Q2 Results FY27?\">What are Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_is_the_results_date_for_Godavari_Drugs_Q2_Results_FY27\" title=\"What is the results date for Godavari Drugs Q2 Results FY27?\">What is the results date for Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_revenue_was_reported_in_Godavari_Drugs_Q2_Results_FY27\" title=\"What revenue was reported in Godavari Drugs Q2 Results FY27?\">What revenue was reported in Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_net_profit_was_reported_in_Godavari_Drugs_Q2_Results_FY27\" title=\"What net profit was reported in Godavari Drugs Q2 Results FY27?\">What net profit was reported in Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#How_much_YoY_growth_did_revenue_show_in_Godavari_Drugs_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in Godavari Drugs Q2 Results FY27?\">How much YoY growth did revenue show in Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Did_net_profit_rise_or_fall_in_Godavari_Drugs_Q2_Results\" title=\"Did net profit rise or fall in Godavari Drugs Q2 Results?\">Did net profit rise or fall in Godavari Drugs Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_was_the_Operating_Profit_in_Godavari_Drugs_Q2_Results_FY27\" title=\"What was the Operating Profit in Godavari Drugs Q2 Results FY27?\">What was the Operating Profit in Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Are_Godavari_Drugs_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are Godavari Drugs Q2 Results consolidated results or standalone results?\">Are Godavari Drugs Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_business_factors_shaped_Godavari_Drugs_Q2_Results_FY27\" title=\"What business factors shaped Godavari Drugs Q2 Results FY27?\">What business factors shaped Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_are_the_key_risks_after_Godavari_Drugs_Q2_Results_FY27\" title=\"What are the key risks after Godavari Drugs Q2 Results FY27?\">What are the key risks after Godavari Drugs Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#What_is_the_outlook_after_Godavari_Drugs_Q2_Results\" title=\"What is the outlook after Godavari Drugs Q2 Results?\">What is the outlook after Godavari Drugs Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/godavari-drugs-q2-results-fy27-pat-0-96-crore\/#Where_can_I_find_the_complete_Godavari_Drugs_Q2_Results_FY27_data\" title=\"Where can I find the complete Godavari Drugs Q2 Results FY27 data?\">Where can I find the complete Godavari Drugs Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Godavari_Drugs_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>Godavari Drugs Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 28.23 Cr<\/td>\n<td>Rs 26.65 Cr<\/td>\n<td>+5.93% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 2.8 Cr<\/td>\n<td>Rs 2 Cr<\/td>\n<td>+40% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 0.96 Cr<\/td>\n<td>Rs 1 Cr<\/td>\n<td>-4% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for Godavari Drugs Q2 Results FY27, 11 November 2026. Figures in Rs Crore, Standalone basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_Godavari_Drugs_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from Godavari Drugs Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue of Rs 28.23 Cr<\/strong> was up 5.93% YoY, compared with Rs 26.65 Cr in the same quarter of the previous year, according to the Godavari Drugs Q2 Results FY27 data.<\/li>\n<li><strong>Net profit of Rs 0.96 Cr<\/strong> was down 4% YoY from Rs 1 Cr, so the YoY growth in net profit moved separately from revenue.<\/li>\n<li><strong>Operating Profit of Rs 2.8 Cr<\/strong> was up 40% YoY against Rs 2 Cr, which is the middle profit line between revenue and PAT.<\/li>\n<li><strong>Standalone results<\/strong> are what the figures above are based on, and the results were declared on 11 November 2026.<\/li>\n<li><strong>The next section<\/strong> moves from these headline figures to the detailed performance analysis of the quarter.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"Godavari_Drugs_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>Godavari Drugs Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Godavari Drugs reported revenue of Rs 28.23 Cr for the July to September quarter, up 5.93% YoY from Rs 26.65 Cr, while net profit came in at Rs 0.96 Cr, down 4% from Rs 1 Cr. Revenue moved higher while net profit moved lower on a YoY basis, and Operating Profit also moved up 40% YoY to Rs 2.8 Cr.<\/p>\n<p>Across the Godavari Drugs Q2 Results FY27 figures, the revenue line and the profit lines tell different parts of the story. Revenue rose by 5.93% YoY, Operating Profit rose by 40% YoY and net profit fell by 4% YoY. The supplied data confirms these movements but does not establish the specific cause of each one, so the disclosed drivers are covered in the next section.<\/p>\n<p>In this results analysis of Godavari Drugs Q2 Results, investors usually compare the same quarter across years to separate seasonal patterns from changes in the business. The YoY growth rates above follow that approach, and later quarterly results filed by Godavari Drugs will show whether these levels hold. For now, the results analysis turns to the business factors.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth YoY<\/strong> &#8211; The results analysis points to this disclosed driver first: Revenue grew 5.9% year on year to Rs 28.23 Cr in the latest quarter. This sets the revenue base of Rs 28.23 Cr for the Godavari Drugs Q2 Results FY27 reading and anchors the YoY comparison with Rs 26.65 Cr a year earlier.<\/p>\n<p><strong>Revenue Growth Quarter on Quarter<\/strong> &#8211; Revenue was up 1.0% quarter on quarter from Rs 27.96 Cr. It places the latest quarter in sequence with the previous one, and it supports the reading of the quarterly results beyond the YoY comparison alone.<\/p>\n<p><strong>Operating Profit Movement<\/strong> &#8211; Operating Profit was Rs 2.8 Cr against Rs 2 Cr a year earlier, a YoY change of 40% higher. This line sits between revenue and net profit of Rs 0.96 Cr, so it links the top line to the final profit figure in this standalone results filing.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_Godavari_Drugs_Q2_Results\"><\/span><strong>FY27 Outlook After Godavari Drugs Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The Godavari Drugs Q2 Results FY27 cover only one quarter of FY27, so the full-year picture depends on the quarters still to be reported. With net profit at Rs 0.96 Cr and revenue at Rs 28.23 Cr in this quarter, the next results analysis will show how the YoY growth trend builds across the year.<\/p>\n<p>This section avoids any projection and relies only on the declared figures. Investors can track Godavari Drugs on the Univest Screener and in the Univest app to see how net profit and revenue develop as each quarterly result is declared, and the next section covers the risks to watch.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After Godavari Drugs Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Net_Profit_Fell_YoY\"><\/span><strong>Net Profit Fell YoY<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Net profit fell 4.0% year on year to Rs 0.96 Cr. This is a point to read alongside the Godavari Drugs Q2 Results FY27 figures and the standalone results basis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Low_Return_on_Equity\"><\/span><strong>Low Return on Equity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity was low at 7.18% in FY26.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Modest_Return_on_Capital_Employed\"><\/span><strong>Modest Return on Capital Employed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed was modest at 6.81% in FY26. Tracking this against YoY growth in later quarters will show whether the picture changes.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Godavari Drugs Q2 Results FY27 show Godavari Drugs reporting revenue of Rs 28.23 Cr and net profit of Rs 0.96 Cr in July to September 2026 on a Standalone basis. Investors reading the quarterly results and Godavari Drugs Q2 Results data alongside the standalone results may want to consult a SEBI-registered advisor before acting on any of these numbers.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on Godavari Drugs Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What are Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs Q2 Results FY27 cover the July to September 2026 quarter of Godavari Drugs, showing standalone revenue of Rs 28.23 Cr and net profit of Rs 0.96 Cr. The Quick Answer at the top summarises them.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What is the results date for Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs declared its Q2 FY27 results on 11 November 2026, so that is the results date for the July to September 2026 quarter. Alongside this, the intro of this article covers the filing context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What revenue was reported in Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs reported revenue of Rs 28.23 Cr in Godavari Drugs Q2 Results FY27, compared with Rs 26.65 Cr a year earlier, while the Financial Highlights table sets both quarters side by side.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What net profit was reported in Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs reported net profit of Rs 0.96 Cr, against Rs 1 Cr in the same quarter last year, while the Key Takeaways section places this net profit beside revenue and Operating Profit.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue rose 5.93% YoY to Rs 28.23 Cr from Rs 26.65 Cr in the standalone results of Godavari Drugs, which means the YoY growth figure compares the same quarter, as covered in Performance Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_Godavari_Drugs_Q2_Results\"><\/span><strong>Did net profit rise or fall in Godavari Drugs Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit fell 4% YoY in Godavari Drugs Q2 Results, moving to Rs 0.96 Cr from Rs 1 Cr, while the Performance Analysis section sets this against the revenue and Operating Profit movement.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit was Rs 2.8 Cr in Godavari Drugs Q2 Results FY27, up 40% YoY from Rs 2 Cr, which means it is the middle profit line between revenue and net profit, as discussed in Performance Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_Godavari_Drugs_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are Godavari Drugs Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs Q2 Results are standalone results for Godavari Drugs, so every revenue, Operating Profit and net profit figure refers to the standalone basis, as stated in the Quick Answer and again in the Conclusion section.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What business factors shaped Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The disclosed factors for Godavari Drugs Q2 Results FY27 are a 5.93% YoY revenue change and revenue up 1.0% quarter on quarter from Rs 27.96 Cr, so the Key Business Factors section links each one to the quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_Godavari_Drugs_Q2_Results_FY27\"><\/span><strong>What are the key risks after Godavari Drugs Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs lists a YoY fall in net profit, low return on equity and modest return on capital employed as points to watch, so the Key Risks section explains each alongside the Godavari Drugs Q2 Results FY27 figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_Godavari_Drugs_Q2_Results\"><\/span><strong>What is the outlook after Godavari Drugs Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Godavari Drugs Q2 Results cover only the July to September quarter of FY27, so the FY27 outlook depends on later quarterly results. Alongside this, the Outlook section avoids projections and relies only on the declared figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_Godavari_Drugs_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete Godavari Drugs Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete Godavari Drugs Q2 Results FY27 data sits in the Financial Highlights table, which sets revenue, Operating Profit and net profit against the same quarter a year earlier. The Univest Screener also lists the latest Godavari Drugs figures.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs Q2 Results FY27 cover the July to September 2026 quarter of Godavari Drugs, showing standalone revenue of Rs 28.23 Cr and net profit of Rs 0.96 Cr. The Quick Answer at the top summarises them.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs declared its Q2 FY27 results on 11 November 2026, so that is the results date for the July to September 2026 quarter. Alongside this, the intro of this article covers the filing context.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs reported revenue of Rs 28.23 Cr in Godavari Drugs Q2 Results FY27, compared with Rs 26.65 Cr a year earlier, while the Financial Highlights table sets both quarters side by side.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs reported net profit of Rs 0.96 Cr, against Rs 1 Cr in the same quarter last year, while the Key Takeaways section places this net profit beside revenue and Operating Profit.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue rose 5.93% YoY to Rs 28.23 Cr from Rs 26.65 Cr in the standalone results of Godavari Drugs, which means the YoY growth figure compares the same quarter, as covered in Performance Analysis.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in Godavari Drugs Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit fell 4% YoY in Godavari Drugs Q2 Results, moving to Rs 0.96 Cr from Rs 1 Cr, while the Performance Analysis section sets this against the revenue and Operating Profit movement.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit was Rs 2.8 Cr in Godavari Drugs Q2 Results FY27, up 40% YoY from Rs 2 Cr, which means it is the middle profit line between revenue and net profit, as discussed in Performance Analysis.\"}},{\"@type\":\"Question\",\"name\":\"Are Godavari Drugs Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs Q2 Results are standalone results for Godavari Drugs, so every revenue, Operating Profit and net profit figure refers to the standalone basis, as stated in the Quick Answer and again in the Conclusion section.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The disclosed factors for Godavari Drugs Q2 Results FY27 are a 5.93% YoY revenue change and revenue up 1.0% quarter on quarter from Rs 27.96 Cr, so the Key Business Factors section links each one to the quarter.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after Godavari Drugs Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs lists a YoY fall in net profit, low return on equity and modest return on capital employed as points to watch, so the Key Risks section explains each alongside the Godavari Drugs Q2 Results FY27 figures.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after Godavari Drugs Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Godavari Drugs Q2 Results cover only the July to September quarter of FY27, so the FY27 outlook depends on later quarterly results. Alongside this, the Outlook section avoids projections and relies only on the declared figures.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete Godavari Drugs Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete Godavari Drugs Q2 Results FY27 data sits in the Financial Highlights table, which sets revenue, Operating Profit and net profit against the same quarter a year earlier. The Univest Screener also lists the latest Godavari Drugs figures.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"Godavari Drugs Q2 Results FY27: Profit Moves Against Revenue, Revenue Rs 28.23 Cr, PAT Rs 0.96 Cr\",\"description\":\"Godavari Drugs Q2 Results: Standalone revenue \u20b928.23 Cr, PAT \u20b90.96 Cr. Check YoY growth and quarterly results analysis from the 11 November 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"Godavari Drugs Ltd\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Godavari Drugs Q2 Results FY27: standalone revenue Rs 28.23 Cr, PAT Rs 0.96 Cr, declared on 11 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":344176,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-344177","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["344176"],"rank_math_title":["Godavari Drugs Q2 Results FY27: PAT Rs 0.96 Cr, Revenue Rs 28.23 Cr"],"rank_math_description":["Godavari Drugs Q2 Results: Standalone revenue \u20b928.23 Cr, PAT \u20b90.96 Cr. Check YoY growth and quarterly results analysis from the 11 November 2026 filing."],"rank_math_focus_keyword":["Godavari Drugs Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/godavari-drugs-q2-results-fy27-profit-moves-against-revenue-revenue-rs-28-23-cr.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=344177"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/344177\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/344176"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=344177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=344177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=344177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}